Health and Human Safety

Research Involving Recombinant DNA, Infectious Agents, Human Blood or Blood Products, Human or Primate Cell Lines, or Other Biohazardous Materials

Principal Investigators conducting research involving Recombinant DNA, infectious agents, human blood or blood products, human or primate cell lines, or other Biohazardous materials MUST REGISTER with the Biosafety Committee.

All work involving Recombinant DNA that is not exempt under current NIH guidelines, must be reviewed and approved by the University Biosafety Committee before such work can begin.

Registration documents, current NIH/CDC guidance documents, and applicable regulatory documents may be obtained form the Secretary of the Biosafety Committee: Leonard Borzynski (facljb@facilities.buffalo.edu), Environmental Health Officer, Environmental Health & Safety, 301 Michael Hall, South Campus, 829-3301, FAX 829-2516.


Laboratory Use of Toxic, Hazardous, or Carcinogenic Chemicals and Hazardous Waste Disposal

Investigators using toxic, hazardous, or carcinogenic chemicals or materials must prepare a Chemical Hygiene Plan in accordance with 29 CRF 1910.1450, "Occupational Exposure to Hazardous Chemicals in Laboratories." In addition, arrangements for disposal of hazardous wastes, as required by CRF 40 part 262 and New York State 6 NYCRR part 370 series for hazardous waste management, must be made.

Please contact Gene Monacell (monacell@acsu.buffalo.edu), Environmental Health and Safety, 307 Michael Hall, South Campus 829-3301, FAX 829-2516, for details.


Use of Radiological Materials/Equipment

Use and ordering of radioactive materials and radiation producing equipment on the University campuses, in the BGH Multi-Lab Building and the Research Institute on Addictions requires prior approval by Radiation Protection Services (RPS) and the Campus Radioisotope Safety Committee.

Radiation Protection Services
14 Parker Hall
South Campus


Contact Person: Mark Pierro, Safety Officer
Telephone: 829-3281
Fax: 829-2029

Notify RPS if your experimental protocols include any of the following procedures or equipment:

  1. Radioactive materials in an in vitro assay.
  2. Radioactive materials experimentally in vivo (animals or humans).
  3. Radioactive materials in student laboratory experiments.
  4. Electroplated or sealed radioactive sources (e.g. electron capture devices).
  5. Radiographic, fluoroscopic, x-ray defraction or other devices emitting ionizing radiation.

Ordering of radioactive materials requires the use of the RPS Radioactive Materials Purchase Requisition. All radioactive materials are received at 14 Parker and delivered to laboratories by RPS.